🇺🇸 FDA
Patent

US 7638639

Substituted pyrrolidine and related compounds

granted A61KA61K31/40A61P

Quick answer

US patent 7638639 (Substituted pyrrolidine and related compounds) held by Theravance, Inc. expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K31/40, A61P, A61P11/06, A61P11/08